Fan et al have suggested that IFN-γ may restore sensitivity by upregulating HER2/neu expression, increasing the binding of 131I-Herceptin, and improving the inhibitory effect of 131I-Herceptin on proliferation of breast cancer cells [86]. The gene discussed is ERBB2; the disease is breast cancer.